Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Sharp Blames Actions By Agency for Its Exit of Accountable Care Organization

HEALTH: Sharp Says Moves By CMS Changed Savings to a LossSharp HealthCare is considering its legal options after earlier this year withdrawing from a Medicare program in which health systems shoulder greater accountability.

Acadia’s Stock Surges on FDA Reaffirming Drug

The U.S. Food and Drug Administration didn’t find new safety concerns after reexamining Acadia Pharmaceutical’s drug to treat hallucinations and delusions caused by Parkinson’s disease.

Alliance Healthcare Foundation Awards $2M to Local Organizations

San Diego-based Alliance Healthcare Foundation established has a new $2 million fund with the San Diego Foundation. That money will be split between the Multicultural Health Foundation and Somali Family Services.

Life Sciences Reporter's Notebook: Clearity Marks 10 Years in Ovarian Cancer Fight

Laura Shawver — perhaps best known as the CEO of Synthorx — launched the Clearity Foundation after her own experience with ovarian cancer.

Tease photo

Samumed Inks Licensing Deal Worth Up To $350M

United Therapeutics Corporation gained North American licensing rights to a lung disease drug from San Diego’s Samumed in a deal announced Sept. 17.

Illumina’s Progress Creates Encouraging Ecosystem for Others

In 2000, the cost to sequence a genome stood at $100 million.

Tease photo

ViaCyte Set to Receive $15M in Diabetes Collaboration

ViaCyte, a San Diego stem cell therapy biotech, has teamed up with a Massachusetts gene-editing company to take on diseases like diabetes.

Sherpa Clinical Packaging Acquired

San Diego-based Sherpa Clinical Packaging has been acquired by PCI Pharma Services under a deal announced Sept. 11 in which terms were not disclosed.

Vital Therapies Abandons Liver Treatment After Clinical Trial

San Diego’s Vital Therapies on Sept. 12 scrapped a cell-based therapy intended to treat acute liver failure following final-stage clinical trials, sending the company’s stock plummeting.

Epic Sciences Pulls in $52M Series E Round

Epic Sciences on Sept. 12 hauled in a $52 million Series E round to advance a portfolio of tests.

Exagen Diagnostics Launches Blood Test for Managing Rheumatoid Arthritis

Vista-based Exagen Diagnostics launched a blood test for added insight in managing rheumatoid arthritis.

Ramping up its Commercial Strategy, Halozyme Hires a CCO

Halozyme Therapeutics hired pharmaceutical veteran Benjamin Hickey as the company’s chief commercial officer, it was recently announced.

ResMed Files Lawsuit Over Alleged Patent Infringements

A patent dispute between ResMed and Fisher & Paykel Healthcare has escalated.

Tease photo

$65 Million Pledged for UCSD Drug Development Partnership

A New York investment management firm has pledged $65 million to a new venture with UC San Diego to bridge the divide between basic research and clinical trials.

Gary and Mary West Foundation Helps Establish Not-For-Profit Generic Drug Co.

San Diego’s Gary and Mary West Foundation is helping get off the ground Civica RX, a new not-for-profit generic drug company with the goal of tackling shortages and high prices on life-saving medications.